Revenue increased 1% to $5.8MAdjusted EBITDA increased $900,000 to $871,000 in Q4 2024Cash flow from operations increased to $353,000 from ...
BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback